Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Benedikt Bernd Claus, Michael Specka, Heath MacAnally, Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)
29 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology